Rituximab (RTX) Therapy in Patients With Active TAO

NCT02378298 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Ophthalmopathy, Thyroid-Associated

Interventions

DRUG: Rituximab
DRUG: Iv Methylprednisolone
DRUG: peroral methylprednisolone and Methotrexate

Sponsor

Göteborg University

Collaborators

[object Object]